Evidence map›Paper›PMID 40666627›Full record

ArticleDigital health

Dual-stage segmentation and classification framework for skin lesion analysis using deep neural network.

Khadija Manzoor, Nauman U Gilal, Marco Agus, Jens Schneider

Abstract read
In one paragraph

Article in Digital health. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Khadija ManzoorCollege of Science and Engineering, Hamad Bin Khalifa University, Doha, Qatar.ORCID https://orcid.org/0009-0009-5430-9795
Nauman U GilalQatar Computing Research Institute, Hamad Bin Khalifa University, Doha, Qatar.ORCID https://orcid.org/0000-0002-8197-4696
Marco AgusCollege of Science and Engineering, Hamad Bin Khalifa University, Doha, Qatar.ORCID https://orcid.org/0000-0003-2752-3525
Jens SchneiderCollege of Science and Engineering, Hamad Bin Khalifa University, Doha, Qatar.ORCID https://orcid.org/0000-0002-0546-2816

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Skin diseases, caused by various pathogens including bacteria, viruses, and fungi, are prevalent globally and significantly affect patients' physical, emotional, and social well-being. Early and accurate detection of such conditions is critical to prevent progression, especially in cases of malignant skin lesions. This study aims to develop a dual-stage deep learning framework for the segmentation and classification of skin lesions, addressing challenges such as imbalanced data, lesion variability, and low contrast. Methods: We propose a two-phase framework: (i) Precise instance segmentation using U-Net with a Visual Geometry Group (VGG16 encoder) to isolate skin lesions and (ii) classification using EfficientFormer and SwiftFormer networks to evaluate performance on both balanced and imbalanced datasets. Experiments were conducted on three benchmark datasets: Human against machine with 10,000 training images (HAM10000), International Skin Imaging Collaboration (ISIC) 2018, and the newly released ISIC 2024 SLICE-3D dataset. For SLICE-3D, we evaluated both tabular-only and image + metadata fusion approaches using XGBoost classifier and ResNet-based classifier, respectively. Results: On the balanced HAM10000 dataset, EfficientFormerV2 achieved 97.11% accuracy, a 97.14% Conclusion: The proposed dual-stage deep learning framework demonstrates high accuracy and robustness across segmentation and classification tasks on diverse datasets. Its adaptability to large-scale, non-dermoscopic data such as SLICE-3D confirms its potential for deployment in real-world skin cancer triage and teledermatology applications.

Indexed as

deep learningimage augmentationskin cancerskin disease classificationSkin lesion segmentation

Identifiers

PMID40666627
PMCPMC12260298

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.